104160 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Comprehensive Evaluation of the 

Implementation and Uptake of the CDC 

Clinical Practice Guideline for 

Prescribing Opioids for Pain—New— 

National Center for Injury Prevention 

and Control (NCIPC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Beginning in the 1990s, opioid 

prescribing rates for pain management 

steadily increased until 2010, remained 

steady until 2012, and have declined 

since then. The increase in opioid 

prescribing rates corresponded with 

increases in opioid-involved overdose 

deaths, which initially primarily 

involved prescription opioids (natural 

and semi-synthetic opioids and 

methadone). In response to this 

emerging crisis, CDC issued the CDC 

Guideline for Prescribing Opioids for 

Chronic Pain—United States, 2016 

(2016 CDC Guideline). Implementing 

the 2016 CDC Guideline was associated 

with reductions in opioid prescribing 

and increases in use of non-opioid 

medications for pain. At the same time, 

laws and policies related to prescribing 

opioids were instituted that misapplied 

or were inconsistent with the 2016 CDC 

Guideline, potentially contributing to 

patient harm. In 2022, CDC released the 

CDC Clinical Practice Guideline for 

Prescribing Opioids for Pain—United 

States, 2022, (2022 CDC Clinical 

Practice Guideline) which provided up 

to date evidence regarding pain 

management approaches and reemphasizes the need for prescribers to 

be focused on patient-centered care to 

provide effective pain management. 

CDC is comprehensively evaluating the 

uptake, implementation, and outcomes 

of the 2022 CDC Clinical Practice 

Guideline on evidence-based care for 

pain management to understand its 

impact. 

To meet CDC’s goal for a rigorous, 

comprehensive evaluation, this 

collection is proposing a mixed-method 

quasi-experimental approach to evaluate 

the 2022 CDC Clinical Practice 

Guideline. The evaluation includes 

dissemination and impact of the 2022 

CDC Clinical Practice Guideline through 

population-wide changes in prescribing 

practices for opioids and medications 

for opioid use disorder. Also, evaluation 

of the implementation of the 2022 CDC 

Clinical Practice Guideline comes from 

perspectives of patients, caregivers, 

clinicians; and leaders from health 

systems, payers, professional 

associations, and medical boards. 

CDC will use this information 

collection to evaluate the dissemination, 

impact, and implementation of the 2022 

CDC Clinical Practice Guideline to 

ensure that Americans have access to 

safer, effective ways of managing their 

pain. CDC requests OMB approval for an 

estimated 310 annual burden hours. 

There are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Clinicians ......................................................... Clinician Survey .............................................

Invitation .........................................................

200 

1000 

1 

1 

10/60 

5/60 

Follow up Emails ............................................ 1000 1 5/60 

Clinician Interview .......................................... 10 1 1 

Dentists ........................................................... Dentist Interview ............................................. 2 1 1 

Health System Leaders .................................. Health System Leaders Interview .................. 3 2 1 

Payers ............................................................. Payer Interview .............................................. 3 2 1 

Professional Association Leaders ................... Professional Association Leaders Interview .. 3 2 1 

Medical Board Leaders ................................... Medical Board Leaders Interview .................. 3 2 1 

Patients ........................................................... Patient Focus Groups .................................... 15 3 1 

Caregivers ....................................................... Caregiver Focus Groups ................................ 15 2 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–30482 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–0234] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Ambulatory Medical Care Survey 

(NAMCS)’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on 

September 20, 2024 to obtain comments 

from the public and affected agencies. 

CDC did not receive comments related 

to the previous notice. This notice 

serves to allow an additional 30 days for 

public and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 104161 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

National Ambulatory Medical Care 

Survey (NAMCS) (OMB Control No. 

0920–0234, Exp. 11/30/2025)— 

Revision—National Center for Health 

Statistics (NCHS), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The National Ambulatory Medical 

Care Survey (NAMCS) was conducted 

intermittently from 1973 through 1985, 

and annually since 1989. The survey is 

conducted under authority of Section 

306 of the Public Health Service Act (42 

U.S.C. 242k). NAMCS is part of the 

Ambulatory Care Component of the 

National Health Care Surveys (NHCS), a 

family of provider-based surveys that 

capture health care utilization from a 

variety of settings, including hospital 

inpatient and long-term care facilities. 

NHCS surveys of health care providers 

include NAMCS, the National 

Electronic Health Records Survey 

(NEHRS, OMB Control No. 0920–1015), 

the National Hospital Care Survey (OMB 

Control No. 0920–0212), and the 

National Post-acute and Long-term Care 

Study (OMB Control No. 0920–0943). 

An overarching purpose of NAMCS is 

to meet the needs and demands for 

statistical information about the 

provision of ambulatory medical care 

services in the United States. This 

fulfills one of NCHS missions; to 

monitor the nation’s health. In addition, 

NAMCS provides ambulatory medical 

care data to study: (1) the performance 

of the U.S. health care system; (2) care 

for the rapidly aging population; (3) 

changes in services such as health 

insurance coverage change; (4) the 

introduction of new medical 

technologies; and (5) the use of 

electronic health records (EHRs). 

Ongoing societal changes have led to 

considerable diversification in the 

organization, financing, and 

technological delivery of ambulatory 

medical care. This diversification is 

evidenced by the proliferation of 

insurance and benefit alternatives for 

individuals, the development of new 

forms of physician group practices and 

practice arrangements (such as officebased practices owned by hospitals), the 

increasing role of advanced practice 

providers delivering clinical care, and 

growth in the number of alternative sites 

of care. 

Ambulatory services are rendered in a 

wide variety of settings, including 

physician/provider offices and hospital 

outpatient and emergency departments. 

Since more than 65% of ambulatory 

medical care visits occur in physician 

offices, NAMCS provides data on the 

majority of ambulatory medical care 

services. In addition to health care 

provided in physician offices and 

outpatient and emergency departments, 

health centers (HCs) play an important 

role in the health care community by 

providing care to people who might not 

be able to afford it otherwise. HCs are 

local, non-profit, community-owned 

health care settings, which serve 

approximately over 30 million 

individuals throughout the United 

States. 

This Revision seeks approval to 

conduct changes to all three 

components of NAMCS. We plan to 

adjust the HC Component and Provider 

Survey Component sample sizes. In 

2025 the goal is to sample 10,000 

advanced practice providers and up to 

151 HCs. In 2026 CDC plans to sample 

up to 10,000 physicians and up to 171 

HCs. Lastly, if funds allow, in 2027 we 

will sample up to 10,000 advanced 

practice providers and up to 191 HCs. 

For 2025–2027, there will be an 

additional 3,000 providers sampled 

yearly for the Provider Electronic 

Component. Additionally, questions on 

the Provider Facility Interview, Health 

Center Facility Interview and the 

Ambulatory Care Provider Interview 

will be modified. CDC requests OMB 

approval for an estimated annual 22,107 

burden hours. There is no cost to 

respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Avg. burden 

per response 

(in hrs.) 

HC’s Staff ......................................... HC Facility Interview Questionnaire (Survey year: 

2024).

84 1 45/60 

Prepare and transmit EHR for Visit Data (quarterly) 

(Survey year: 2024).

50 4 60/60 

Set-up Fee Questionnaire (Survey year: 2024) ........... 17 1 15/60 

Provider or Staff ............................... ACPI (Survey year: 2026) ............................................. 3,333 1 30/60 

Contact Tracing (Survey year: 2026) ........................... 3,333 1 10/60 

Advanced Practice Provider or Staff ACPI (Survey year: 2025 & 2027) ................................ 6,667 1 30/60 

Contact Tracing (Survey year: 2025 & 2027) ............... 6,667 1 10/60 

Ambulatory Care Provider’s or 

Group’s or Conglomerate’s Staff.

PFI (Survey year: 2025–2027) .....................................

Prepare and transmit Electronic Visit Data (quarterly) 

(Survey year: 2025–2027).

3000 

3000 

1 

4 

45/60 

60/60 

HC’s Staff ......................................... HC Facility Interview Questionnaire (Survey year: 

2025–2027).

221 1 45/60 

Prepare and transmit EHR for Visit Data (quarterly) 

(Survey year: 2025–2027).

188 4 60/60 

Set-up Fee Questionnaire (Survey year: 2025–2027) 17 1 15/60 


ddrumheller on DSK120RN23PROD with NOTICES1
104162 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–30480 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Safety and Occupational Health Study 

Section; Notice of Solicitation of 

Nominations for Appointment; 

Correction 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice; correction. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), within the 

Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Safety and 

Occupational Health Study Section 

(SOHSS). SOHSS consists of 20 experts 

in fields associated with occupational 

medicine and nursing, industrial 

hygiene, occupational safety and 

engineering, toxicology, chemistry, 

safety and health education, 

ergonomics, epidemiology, economic 

science, psychology, pulmonary 

pathology/physiology, and social 

science. 

DATES: Nominations for membership on 

SOHSS must be received no later than 

January 31, 2025. Packages received 

after this time will not be considered for 

the current membership cycle. 

ADDRESSES: All nominations should be 

mailed to Dr. Michael Goldcamp, 1095 

Willowdale Road, Morgantown, West 

Virginia 26505 or emailed to 

MGoldcamp@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Michael Goldcamp, Ph.D., Scientific 

Review Officer, Office of Extramural 

Programs, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1095 Willowdale Road, Morgantown, 

West Virginia 26505. Telephone: (304) 

285–5951; email: MGoldcamp@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Correction 

Notice is hereby given of a correction 

in the SUPPLEMENTARY INFORMATION

section of the original solicitation of 

nominations notice, which was 

published in the Federal Register on 

December 2, 2024, 89 FR 95214. 

The notice is being amended to 

remove the sentence concerning Special 

Government Employees, since members 

of the Safety and Occupational Health 

Study Section serve as Peer Review 

Consultants. The SUPPLEMENTARY

INFORMATION section should read as 

follows: 

SUPPLEMENTARY INFORMATION: 

Nominations are sought for individuals 

who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the objectives of 

the Safety and Occupational Health 

Study Section (SOHSS). Nominees will 

be selected based on expertise in the 

fields of occupational medicine and 

nursing, industrial hygiene, 

occupational safety and engineering, 

toxicology, chemistry, safety and health 

education, ergonomics, epidemiology, 

economic science, psychology, 

pulmonary pathology/physiology, and 

social science. Members may be invited 

to serve up to four-year terms. Selection 

of members is based on candidates’ 

qualifications to contribute to the 

accomplishment of SOHSS objectives 

(https://www.cdc.gov/faca/committees/ 

sohss.html). 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on Federal workgroups or 

prior experience serving on a Federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. The Centers 

for Disease Control and Prevention 

(CDC) reviews potential candidates for 

SOHSS membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in October 2025, or 

as soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. 

Candidates should submit the 

following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by HHS. Candidates may 

submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, Food and 

Drug Administration). 

Nominations may be submitted by the 

candidate or by the person/organization 

recommending the candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–30410 Filed 12–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Sole Source 

Cooperative Agreement to Fund 

Secretaria Ejecutiva del Consejo de 

Ministros de Salud de Centroamerica y 

Republica Dominicana (SE–COMISCA) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $5,000,000, 

with an expected total funding of 

approximately $25,000,000 over a 5-year 

period, to SE–COMISCA. The award 

will build upon previous efforts by the 

CDC in collaboration with Ministries of 

Health of Central America and the 

Dominican Republic (SE–COMISCA). 

DATES: The period for this award will be 

September 30, 2025 through September 

29, 2030. 


ddrumheller on DSK120RN23PROD with NOTICES1